Matthew J. Ferris

552 total citations
36 papers, 348 citations indexed

About

Matthew J. Ferris is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology. According to data from OpenAlex, Matthew J. Ferris has authored 36 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 10 papers in Otorhinolaryngology. Recurrent topics in Matthew J. Ferris's work include Head and Neck Cancer Studies (10 papers), Brain Metastases and Treatment (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Matthew J. Ferris is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Brain Metastases and Treatment (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Matthew J. Ferris collaborates with scholars based in United States, Canada and Australia. Matthew J. Ferris's co-authors include Jeffrey M. Switchenko, Walter J. Curran, Bree R. Eaton, Kirtesh R. Patel, Kristin Higgins, Robert H. Press, Mudit Chowdhary, Richard J. Cassidy, Jeffrey J. Olson and Jonathan J. Beitler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Matthew J. Ferris

31 papers receiving 346 citations

Peers

Countries citing papers authored by Matthew J. Ferris

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Ferris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Ferris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Ferris more than expected).

Fields of papers citing papers by Matthew J. Ferris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Ferris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Ferris. The network helps show where Matthew J. Ferris may publish in the future.

Co-authorship network of co-authors of Matthew J. Ferris

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Ferris. A scholar is included among the top collaborators of Matthew J. Ferris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Ferris. Matthew J. Ferris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nutritional Outcomes in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma After Transoral Robotic Surgery 2025 ·The Laryngoscope ·(unknown), Jane Y. Tong, Matthew J. Ferris, Jason K. Molitoris, Kyle M. Hatten	0
2	Adjuvant Proton Radiation Following Transoral Robotic Surgery for HPV‐Positive Oropharyngeal Squamous Cell Carcinoma 2025 ·Otolaryngology ·Jane Y. Tong, (unknown), Matthew J. Ferris, Jason K. Molitoris, Kyle M. Hatten	0
3	Graph feature selection for enhancing radiomic stability and reproducibility across multiple institutions in head and neck cancer 2025 ·Scientific Reports ·(unknown), Jason K. Molitoris, Ling Xiao, Lisa M. Schumaker, (unknown), Hannah Thomas, (unknown), Matthew J. Ferris, (unknown), (unknown), Phuoc T. Tran, Amit Sawant, Ranee Mehra, Daria A. Gaykalova, Lei Ren	0
4	Phase 2 randomized study of high-risk metachronous oligometastatic prostate cancer with high-risk mutations treated with metastasis-directed therapy and niraparib/abiraterone acetate plus prednisone (KNIGHTS) trial. 2025 ·Journal of Clinical Oncology ·Matthew P. Deek, Xiaolei Shi, Noura Radwan, (unknown), (unknown), Zaker Rana, Matthew J. Ferris, Young Kwok, Søren M. Bentzen, Ronald D. Ennis, Lara Hathout, Biren Saraiya, Tina Mayer, Heather D. Mannuel, Arif Hussain, Matthew C. Abramowitz, Alejandro Berlín, Mark V. Mishra, Phuoc T. Tran, Jason K. Molitoris	1
5	Platelet specific knockout of integrin beta-3 (β3) reduces severity of necrotizing enterocolitis in murine neonates 2025 ·Frontiers in Pediatrics ·(unknown), (unknown), (unknown), (unknown), (unknown), Matthew J. Ferris, (unknown), (unknown), Liza Konnikova, Krishnan MohanKumar	0
6	Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer 2024 ·Oral Oncology ·(unknown), (unknown), Jason K. Molitoris, Matthew J. Ferris, Yang Song, Amol C. Shetty, Ranee Mehra, John C. Papadimitriou, Kyle M. Hatten, R. Taylor, Jeffrey S. Wolf, Kai Sun, Søren M. Bentzen, (unknown), Phuoc T. Tran, Matthew E. Witek	1
7	Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric modulated arc therapy and pencil beam scanning proton therapy 2024 ·Radiotherapy and Oncology ·(unknown), Peter T. Campbell, Kai Sun, Jason K. Molitoris, Akshar N. Patel, Matthew E. Witek, Kevin J. Cullen, Ranee Mehra, Kyle M. Hatten, (unknown), Rodney J. Taylor, Kalpesh T. Vakharia, Jeffrey S. Wolf, Matthew J. Ferris	1
8	Pencil Beam Scanning Proton Therapy as Single Vocal Cord Irradiation for Early-Stage Glottic Cancer 2024 ·International Journal of Particle Therapy ·(unknown), (unknown), Jason K. Molitoris, Matthew E. Witek, (unknown), Mark J. Zakhary, (unknown), (unknown), Elizabeth Guardiani, Matthew J. Ferris	0
9	Is noncoplanar plan more robust to inter‐fractional variations than coplanar plan in treating bilateral HN tumors with pencil‐beam scanning proton beams? 2023 ·Journal of Applied Clinical Medical Physics ·B Yi, (unknown), Wei Deng, Yannick Poirier, Weiguang Yao, Matthew E. Witek, Jason K. Molitoris, Mark J. Zakhary, Baoshe Zhang, Nrusingh C. Biswal, Matthew J. Ferris, Sina Mossahebi	2
10	Phase 2 randomized total eradication of metastatic lesions following definitive radiation to the prostate in de novo oligometastatic prostate cancer (TERPs) trial. 2023 ·Journal of Clinical Oncology ·Zaker Rana, (unknown), (unknown), (unknown), Jason K. Molitoris, Matthew J. Ferris, Akshar Patel, Young Kwok, Sarah McAvoy, (unknown), (unknown), Matthew P. Deek, Philip Sutera, Rebecca A. Deek, Søren M. Bentzen, Minhaj Siddiqui, Heather D. Mannuel, Arif Hussain, Phuoc T. Tran, Mark V. Mishra	1
11	Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer 2023 ·Frontiers in Oncology ·Roman O. Kowalchuk, Grant M. Spears, (unknown), Dawn Owen, Harry H. Yoon, Krishan R. Jethwa, Michael D. Chuong, Matthew J. Ferris, Michael G. Haddock, Christopher L. Hallemeier, Dennis A. Wigle, Steven H. Lin, Kenneth W. Merrell	3
12	Factors Related to Small- and Mid-Capitalization Pharmaceutical Company Success Using Stock Performance as a Surrogate 2021 ·Cureus ·Matthew J. Ferris, Kai Sun, (unknown), (unknown), Mark V. Mishra	1
13	Impact of Metastasectomy and Aggressive Local Therapy in Newly Diagnosed Metastatic Soft Tissue Sarcoma: An Analysis of the NCDB 2021 ·Annals of Surgical Oncology ·(unknown), James Janopaul‐Naylor, Jeffrey M. Switchenko, Sibo Tian, William L. Read, Robert H. Press, Shervin V. Oskouei, Nickolas B. Reimer, Matthew J. Ferris, Richard J. Cassidy, Madhusmita Behera, David K. Monson, Jerome C. Landry, Karen D. Godette, Pretesh Patel	3
14	Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer 2019 ·Practical Radiation Oncology ·Matthew J. Ferris, (unknown), Jeffrey M. Switchenko, (unknown), Jonathan Wolf, (unknown), Robert H. Press, Walter J. Curran, Kristin Higgins	25
15	The addition of chemotherapy in the definitive management of high risk prostate cancer 2018 ·Urologic Oncology Seminars and Original Investigations ·Matthew J. Ferris, Yuan Liu, Jingning Ao, Jim Zhong, (unknown), Theresa Gillespie, Bradley Curtis Carthon, Mehmet Asım Bilen, Ömer Küçük, Ashesh B. Jani	5
16	Radiation Therapy Is Associated With an Increased Incidence of Cardiac Events in Patients with Small Cell Lung Cancer 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Matthew J. Ferris, Renjian Jiang, Madhusmita Behera, Suresh S. Ramalingam, Walter J. Curran, Kristin Higgins	14
17	Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities 2017 ·Practical Radiation Oncology ·Jim Zhong, Matthew J. Ferris, Jeffrey M. Switchenko, Robert H. Press, Zachary S. Buchwald, Jeffrey J. Olson, Bree R. Eaton, Walter J. Curran, Hui‐Kuo G. Shu, Ian Crocker, Kirtesh R. Patel	10
18	Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy 2017 ·Radiotherapy and Oncology ·Matthew J. Ferris, Jim Zhong, Jeffrey M. Switchenko, Kristin Higgins, Richard J. Cassidy, Mark W. McDonald, Bree R. Eaton, Kirtesh R. Patel, Conor Steuer, H. Michael Baddour, Andrew H. Miller, Deborah Watkins Bruner, Canhua Xiao, Jonathan J. Beitler	23
19	Reproducibility in contouring the neurovascular bundle for prostate cancer radiation therapy 2017 ·Practical Radiation Oncology ·Richard J. Cassidy, Sherif G. Nour, Tian Liu, Jeffrey M. Switchenko, Sibo Tian, Matthew J. Ferris, Robert H. Press, Jim Zhong, (unknown), Peter J. Rossi, Ashesh B. Jani	10
20	Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Matthew J. Ferris, (unknown), Jeffrey M. Switchenko, (unknown), Bradley George, Kelly C. Goldsmith, Karen Wasilewski, (unknown), Mohammad K. Khan, Bree R. Eaton, Natia Esiashvili	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact